MICHAEL D CANNON Insider Trading $MBRX Moleculin Biotech, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL D CANNON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL D CANNON. MICHAEL D CANNON is Chief Executive Officer in SICOR INC ($SCRI) and Chief Scientific Officer in SICOR INC ($SCRI) and in Athenex, Inc. ($ATNX) and Director in Moleculin Biotech, Inc. ($MBRX).
MICHAEL D CANNON in Moleculin Biotech, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL D CANNON: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 17 2020
$MBRX Market Capitalization: $18.08M
$MBRX Previous Close: $1.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL D CANNON in Moleculin Biotech, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATNX, MBRX, SCRI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2020 | MBRX | Moleculin Biotech, ... | CANNON MICHAEL D | Director | Option Exercise | A | 1.12 | 15,000 | 16,800 | 100,000 | |
| Jul 15 2019 | MBRX | Moleculin Biotech, ... | CANNON MICHAEL D | Director | Option Exercise | A | 1.31 | 35,000 | 45,850 | 120,000 | |
| May 24 2019 | MBRX | Moleculin Biotech, ... | CANNON MICHAEL D | Director | Option Exercise | A | 1.15 | 15,000 | 17,250 | 85,000 | |
| Jun 08 2018 | MBRX | Moleculin Biotech, ... | CANNON MICHAEL D | Director | Option Exercise | A | 1.82 | 35,000 | 63,700 | 70,000 | |
| Jul 26 2017 | MBRX | Moleculin Biotech, ... | CANNON MICHAEL D | Director | Option Exercise | A | 1.87 | 15,000 | 28,050 | 35,000 | |
| Sep 27 2016 | MBRX | Moleculin Biotech, ... | CANNON MICHAEL D | Director | Option Exercise | A | 5.71 | 20,000 | 114,200 | 20,000 |
Page: 1